Zura Bio Limited Warrants
ZURAW
ZURAW was delisted on the 27th of August, 2024.
10 hedge funds and large institutions have $1.85M invested in Zura Bio Limited Warrants in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$346K |
| 2 |
BGIM
Boussard & Gavaudan Investment Management
London,
United Kingdom
|
+$109K |
| 3 |
SCC
Spring Creek Capital
Wichita,
Kansas
|
+$87.5K |
| 4 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
+$72.9K |
| 5 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$58.3K |
Top Sellers
ZURAW Hedge Fund Activity: Q3 2021 in Review
10 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Zura Bio Limited Warrants (ZURAW) for Q3 2021, worth a combined $1.85M.
Buyers outnumbered sellers: 10 funds opened new ZURAW positions and 0 closed out — a net gain of 10 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Hudson Bay Capital Management, opening a new position worth an estimated $346K.
- 10 institutional investors held Zura Bio Limited Warrants (ZURAW) as of Q3 2021, up from 0 in Q2 2021.
- Funds reported $1.85M of Zura Bio Limited Warrants stock for Q3 2021.
- 10 funds opened new Zura Bio Limited Warrants positions in Q3 2021 and 0 closed out, a net change of +10 holders.
- The largest Zura Bio Limited Warrants buyer in Q3 2021 was Hudson Bay Capital Management, an estimated $346K added.
Based on aggregated 13F filings for Q3 2021.